Blood Stem Cells Permanently Damaged by Alcohol

Bone marrow stem cells are extremely sensitive to the primary by-product of alcohol, which causes permanent damage to their DNA claims researchers from the Medical Research Council (MRC) Lab of Molecular Biology.

The research, which was conducted on mice, uncovers two mechanisms that normally control this type of damage; a protein group that recognizes and repairs DNA damage and an enzyme that eliminates acetaldehyde, alcohol’s toxic breakdown product.

Mice lacking both protective mechanisms developed bone marrow failure stemming from blood stem cell damage.
These results mark the first time that scientists have been able to explain why bone marrow fails in Fanconi anemia (FA) patients. FA is a rare genetic disorder.

The report concludes that FA turns off the bone marrow’s “repair kit” via FA gene mutation which causers DNA damage from acetaldehyde to continue unchecked. This damage is responsible for bone marrow failure and developmental defects in FA patients and makes them especially vulnerable to blood and other types of cancer.

These findings may have particular significance for the world’s Asian population, many of whom suffer from “Asian flush syndrome”. People with AFS lack the enzyme ALDH2 and therefore could be particularly susceptible to DNA damage. The authors warned that this subset of the Asian population could suffer permanent DNA damage with alcohol consumption and be more highly prone to blood cancer, bone marrow failure and premature aging than the Asian population at-large.

“Blood stem cells are responsible for providing a continuous supply of healthy blood cells throughout our lifespan. With age, these vital stem cells become less effective because of the build up of damaged DNA. Our study identifies a key source of this DNA damage and defines two protective mechanisms that stem cells use to counteract this threat. Last year we published a paper showing that without this two-tier protection, alcohol breakdown products are extremely toxic to the blood. We now identify exactly where this DNA damage is occurring, which is important because it means that alcohol doesn’t just kill off healthy circulating cells, it gradually destroys the blood cell factory. Once these blood stem cells are damaged they may give rise to leukaemias and when they are gone they cannot be replaced, resulting in bone marrow failure,” Dr KJ Patel, who is the primary investigator.

“The findings may be particularly significant for a vast number of people from Asian countries such as China, where up to a third of the population are deficient in the ALDH2 enzyme. Alcohol consumption in these individuals could overload their FA DNA repair kit causing irreversible damage to their blood stem cells. The long-term consequences of this could be bone marrow dysfunction and the emergence of blood cancers,” Patel added.

“This study provides much sought-after explanation of the biology underpinning the devastating childhood disease Fanconi anemia. In future this work may underpin new treatments for this genetic disease, which currently is associated with a very poor prognosis. It also helps to inform large numbers of the global population, who are deficient in the ALDH2 enzyme, that drinking alcohol may be inflicting invisible damage on their DNA,” commented Sir Hugh Pelham, director of the MRC Laboratory of Molecular Biology.

Using Stem Cells to Study Alcohol Dependence

One of the major advancements in the area of stem cell research has been the establishment of techniques for "retro-differentiating" of old cells into younger cells. Perhaps one of the best examples of this is the discovery by the Japanese group of Yamanaka the skin cells can be coaxed to take the resemblance of embryonic stem cells by transfection with 4 genes. These cells, called inducible pluripotent stem (iPS) cells have numerous applications in many fields.

From a therapeutic perspective, iPS cells allow for the first time the possibility of "reprogramming" adult cells into younger cells, thus opening the door to autologous stem cell therapy for tissue regeneration. In other words, the therapeutic dream of iPS is for one day to be able to take patient skin cells, transform them into stem cells, and then have a large supply of young cells that can be used for repairing any organ of the body.

The other major area in which iPS cells have made a major contribution is in the field of basic research/drug development. Currently when scientists develop new drugs the drugs are tested in human cancer cells that resemble the tissue that the scientist is interested in. So if someone was developing a drug to stimulate pancreatic cells to produce more insulin, the drug initially would be tested on insulinoma cells. If the drug has some positive effects it is then tested in animals, and if successful, in humans.
There are several problems with this model. The first is that many times the cancer cell lines that resemble healthy tissue do not resemble it well. This causes a lot of drugs that appear to work in cells not to work in animals. To some extent this problem is addressed by using cells derived from humans that are not cancerous. The drawback with this is that human cells are expensive and
possess great variability.

Since iPS cells are capable of generating human cells that are "younger", and since they can be created from skin of people with various diseases, the use of iPS cells to generate cells for drug testing has become very popular. For example, if someone wants to study the effects of drugs on ALS, neurons from ALS patients can be easily created from iPS cells in larger quantities than can be extracted from cadaver sources. Dr. Stormy Chamberlain from the UConn Health Center is performing work using iPS cells to develop an in vitro model of alcoholism. Specifically, skin cells will be extracted from alcoholic and non-alcoholic patients. iPS cells will be generated from these skin cells, and then converted into neurons in tissue culture. The neurons will be assessed for abnormalities that are specific to the alcoholic patients.

A collaborator, Dr. Jonathan Covault stated "As proof of principle, we have used skin cells from six subjects to generate pluripotent stem cells, and we have successfully created neural cultures from three of these to develop mature neurons," says Covault. "Going forward, we will compare neurons derived from healthy subjects with those from alcohol-dependent patients. We’ll be evaluating their ability to support electrical signaling and form neuron-to-neuron connections, as well as their pattern of chemical and gene expression responses to single and repeated exposures to alcohol."